Cargando…

PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation

BACKGROUND: Sterile alpha motif and HD domain 1 (SAMHD1) is a deoxynucleotide triphosphohydrolase (dNTPase) that restricts the infection of a variety of RNA and DNA viruses, including herpesviruses. The anti-viral function of SAMHD1 is associated with its dNTPase activity, which is regulated by seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiada, Farjana, Zhang, Kun, Li, Renfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264492/
https://www.ncbi.nlm.nih.gov/pubmed/34238351
http://dx.doi.org/10.1186/s13578-021-00636-y
_version_ 1783719569474453504
author Saiada, Farjana
Zhang, Kun
Li, Renfeng
author_facet Saiada, Farjana
Zhang, Kun
Li, Renfeng
author_sort Saiada, Farjana
collection PubMed
description BACKGROUND: Sterile alpha motif and HD domain 1 (SAMHD1) is a deoxynucleotide triphosphohydrolase (dNTPase) that restricts the infection of a variety of RNA and DNA viruses, including herpesviruses. The anti-viral function of SAMHD1 is associated with its dNTPase activity, which is regulated by several post-translational modifications, including phosphorylation, acetylation and ubiquitination. Our recent studies also demonstrated that the E3 SUMO ligase PIAS1 functions as an Epstein-Barr virus (EBV) restriction factor. However, whether SAMHD1 is regulated by PIAS1 to restrict EBV replication remains unknown. RESULTS: In this study, we showed that PIAS1 interacts with SAMHD1 and promotes its SUMOylation. We identified three lysine residues (K469, K595 and K622) located on the surface of SAMHD1 as the major SUMOylation sites. We demonstrated that phosphorylated SAMHD1 can be SUMOylated by PIAS1 and SUMOylated SAMHD1 can also be phosphorylated by viral protein kinases. We showed that SUMOylation-deficient SAMHD1 loses its anti-EBV activity. Furthermore, we demonstrated that SAMHD1 is associated with EBV genome in a PIAS1-dependent manner. CONCLUSION: Our study reveals that PIAS1 synergizes with SAMHD1 to inhibit EBV lytic replication through protein–protein interaction and SUMOylation.
format Online
Article
Text
id pubmed-8264492
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82644922021-07-08 PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation Saiada, Farjana Zhang, Kun Li, Renfeng Cell Biosci Research BACKGROUND: Sterile alpha motif and HD domain 1 (SAMHD1) is a deoxynucleotide triphosphohydrolase (dNTPase) that restricts the infection of a variety of RNA and DNA viruses, including herpesviruses. The anti-viral function of SAMHD1 is associated with its dNTPase activity, which is regulated by several post-translational modifications, including phosphorylation, acetylation and ubiquitination. Our recent studies also demonstrated that the E3 SUMO ligase PIAS1 functions as an Epstein-Barr virus (EBV) restriction factor. However, whether SAMHD1 is regulated by PIAS1 to restrict EBV replication remains unknown. RESULTS: In this study, we showed that PIAS1 interacts with SAMHD1 and promotes its SUMOylation. We identified three lysine residues (K469, K595 and K622) located on the surface of SAMHD1 as the major SUMOylation sites. We demonstrated that phosphorylated SAMHD1 can be SUMOylated by PIAS1 and SUMOylated SAMHD1 can also be phosphorylated by viral protein kinases. We showed that SUMOylation-deficient SAMHD1 loses its anti-EBV activity. Furthermore, we demonstrated that SAMHD1 is associated with EBV genome in a PIAS1-dependent manner. CONCLUSION: Our study reveals that PIAS1 synergizes with SAMHD1 to inhibit EBV lytic replication through protein–protein interaction and SUMOylation. BioMed Central 2021-07-08 /pmc/articles/PMC8264492/ /pubmed/34238351 http://dx.doi.org/10.1186/s13578-021-00636-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Saiada, Farjana
Zhang, Kun
Li, Renfeng
PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
title PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
title_full PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
title_fullStr PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
title_full_unstemmed PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
title_short PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
title_sort pias1 potentiates the anti-ebv activity of samhd1 through sumoylation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264492/
https://www.ncbi.nlm.nih.gov/pubmed/34238351
http://dx.doi.org/10.1186/s13578-021-00636-y
work_keys_str_mv AT saiadafarjana pias1potentiatestheantiebvactivityofsamhd1throughsumoylation
AT zhangkun pias1potentiatestheantiebvactivityofsamhd1throughsumoylation
AT lirenfeng pias1potentiatestheantiebvactivityofsamhd1throughsumoylation